# NAION during incretin-based therapy: an optic nerve head still adapted to hypertension

Source: [Medical research : nature.com subject feeds](https://www.nature.com/articles/s41433-026-05032-9) · 2026-11-19 · Medicine
Page: https://themorning.science/story/naion-during-incretin-based-therapy-an-optic-nerve-head-still-adapted-to-hyperte-0f164a0718b43bc6
Kind: research · Impact: medium

## In brief

- A Nature journal article, titled "NAION during incretin-based therapy: an optic nerve head still adapted to hypertension", was listed in a nature.com subject feed dated 2026-11-19.
- The source provided only the title, so the article's findings beyond the title cannot be confirmed from the available material.
- The title links non-arteritic anterior ischaemic optic neuropathy (NAION) with incretin-based therapy and describes the optic nerve head as still adapted to hypertension.

## Why it matters

The title ties a serious optic nerve condition, NAION, to incretin-based therapy, which is relevant to clinicians and patients weighing that treatment's risks. The full article is needed to judge the strength of the findings.

## Coverage

- [NAION during incretin-based therapy: an optic nerve head still adapted to hypertension](https://www.nature.com/articles/s41433-026-05032-9) — Medical research : nature.com subject feeds, 2026-11-19

Tags: naion, incretin, optic-nerve, ophthalmology, medical-research

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
